Arch Therapeutics, Inc.
General ticker "ARTH" information:
- Sector: Health Care
- Industry: Health Care Equipment & Supplies
- Capitalization: $2.0M (TTM average)
Arch Therapeutics, Inc. does not follow the US Stock Market performance with the rate: -30.1%.
Estimated limits based on current volatility of 0.2%: low 0.00$, high 0.00$
Factors to consider:
- Earnings for 9 months up through Q3 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-09-30 to 2025-09-29
- 2023-09-30 to 2024-09-29 estimated range: [0.55$, 2.57$]
- 2024-09-29 to 2025-09-29 estimated range: [0.51$, 2.18$]
Financial Metrics affecting the ARTH estimates:
- Negative: Non-GAAP EPS, $ of -3.17 <= 0.04
- Negative: negative Operating income
- Negative: Shareholder equity ratio, % of -383.40 <= 22.52
- Negative: negative Net income
- Negative: Operating cash flow per share per price, % of -42.61 <= 1.79
- Negative: Industry operating cash flow per share per price (median), % of -6.24 <= 2.82
- Negative: Industry earnings per price (median), % of -8.95 <= 0
Short-term ARTH quotes
Long-term ARTH plot with estimates
Financial data
| YTD | 2021-09-30 | 2022-09-30 | 2023-09-30 |
|---|---|---|---|
| Operating Revenue | $0.01MM | $0.02MM | $0.08MM |
| Operating Expenses | $6.39MM | $5.72MM | $5.12MM |
| Operating Income | $-6.38MM | $-5.71MM | $-5.04MM |
| Non-Operating Income | $0.14MM | $0.43MM | $-1.94MM |
| Interest Expense | $0.15MM | $0.57MM | $3.10MM |
| R&D Expense | $1.35MM | $1.15MM | $0.67MM |
| Income(Loss) | $-6.24MM | $-5.28MM | $-6.98MM |
| Profit(Loss)* | $-6.57MM | $-4.28MM | $-6.98MM |
| Stockholders Equity | $-1.03MM | $-4.19MM | $-7.51MM |
| Inventory | $1.09MM | $1.41MM | $1.36MM |
| Assets | $3.68MM | $2.60MM | $1.96MM |
| Operating Cash Flow | $-5.96MM | $-4.46MM | $-3.37MM |
| Capital expenditure | $0.00MM | $0.00MM | $0.00MM |
| Investing Cash Flow | $-0.00MM | $0.00MM | $-0.00MM |
| Financing Cash Flow | $7.27MM | $2.94MM | $2.85MM |
| Earnings Per Share** | $-5.97 | $-3.56 | $-2.27 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.